Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Global Medical REIT (GMRE-PA) over the last 12 years, with Q2 2025 value amounting to $38.5 million.

  • Global Medical REIT's Capital Expenditures rose 773690.48% to $38.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $120.9 million, marking a year-over-year increase of 26852.97%. This contributed to the annual value of $81.7 million for FY2024, which is 356251.12% up from last year.
  • As of Q2 2025, Global Medical REIT's Capital Expenditures stood at $38.5 million, which was up 773690.48% from $32.0 million recorded in Q1 2025.
  • Over the past 5 years, Global Medical REIT's Capital Expenditures peaked at $75.4 million during Q2 2022, and registered a low of -$2.2 million during Q3 2023.
  • Over the past 5 years, Global Medical REIT's median Capital Expenditures value was $28.2 million (recorded in 2021), while the average stood at $27.6 million.
  • As far as peak fluctuations go, Global Medical REIT's Capital Expenditures crashed by 12361.76% in 2024, and later surged by 773690.48% in 2025.
  • Global Medical REIT's Capital Expenditures (Quarter) stood at $26.5 million in 2021, then crashed by 98.74% to $335000.0 in 2022, then soared by 352.84% to $1.5 million in 2023, then soared by 3222.02% to $50.4 million in 2024, then dropped by 23.62% to $38.5 million in 2025.
  • Its Capital Expenditures stands at $38.5 million for Q2 2025, versus $32.0 million for Q1 2025 and $50.4 million for Q4 2024.